D. Maneval

发表

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.

H. Shepard, M. Vaillancourt, Duane E. Johnson, 1994, Human gene therapy.

Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium

H. Engler, S. Sutjipto, T. Machemer, 2001, Gene Therapy.

Pan‐HER biologics (Hermodulins) for the treatment of cancer

H. Shepard, Pei Jin, Daniel C. Maneval, 2008 .

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

C. Dinney, W. Benedict, B. Hutchins, 2013, The Journal of urology.

p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.

H. Shepard, H. Engler, Duane E. Johnson, 1998, Clinical Cancer Research.

Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

M. Westphal, H. Shepard, S. Sutjipto, 1996, International journal of cancer.

Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma.

J. Gutterman, K. Mujoo, D. Maneval, 1996, Oncogene.

Measurement of Tc‐99m DTPA Serum Clearance for Estimating Glomerular Filtration Rate in Children With Cancer

H. Magill, J. Rodman, D. Maneval, 1993, Pharmacotherapy.

Safety and pharmacokinetics of docetaxel in combination with pegvorhyaluronidase alfa in patients with non‐small cell lung cancer

D. Mager, R. Sekulovich, N. Gabrail, 2021, Clinical and translational science.

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours

R. Korn, M. Borad, P. LoRusso, 2017, British Journal of Cancer.

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44

H. Shepard, B. Blouw, C. Thanos, 2019, OncoTarget.

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Derek S. Chan, D. Tuveson, J. Skepper, 2012, Gut.

Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration

B. Sugarman, M. Printz, D. Kang, 2022, The AAPS Journal.

JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis

C. Monnig, Sergio Corrales-Guerrero, Sindhu Nair, 2023, Molecular therapy oncolytics.

Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors.

H. Shepard, D. G. Heimann, D. Maneval, 1996, Blood.

Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.

K. Chan, S. Pandol, J. Gong, 2022, Gastroenterology.

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors

H. Wakimoto, J. Basilion, R. Bookstein, 2002, Cancer Gene Therapy.

Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.

K. Wills, T. Machemer, D. Maneval, 1995, Cancer gene therapy.

A phase Ib study of gemcitabine plus PEGPH20 (pegylated recombinant human hyaluronidase) in patients with stage IV previously untreated pancreatic cancer.

R. Holcombe, P. Jiang, S. Hingorani, 2013 .